The Current Status of Engineering Myocardial Tissue

Myocardial infarction (MI) remains a common fatal disease all over the world. The adult cardiac myocytes regenerative capability is very limited after infarct injury. Heart transplantation would be the best therapeutic option currently but is restricted due to the lack of donor organs and the serious side effects of immune suppression. The emerging of tissue engineering has evolved to provide solutions to tissue repair and replacement. Engineering myocardial tissue is considered to be a new therapeutic approach to repair infarcted myocardium and ameliorate cardiac function after MI. Engineering myocardial tissue is the combination of biodegradable scaffolds with viable cells and has made much progress in the experimental phase. However, the largest challenge of this field is the revascularization of the engineering constructs to provide oxygen and nutrients for cells. This review will give an overview on the current evolution of engineering myocardial tissue and address a new method to improve the vascularization of myocardium tissue in vivo.

[1]  Chunhui Xu,et al.  Formation of human myocardium in the rat heart from human embryonic stem cells. , 2005, The American journal of pathology.

[2]  R. Weisel,et al.  Survival and function of bioengineered cardiac grafts. , 1999, Circulation.

[3]  J. Rana,et al.  Embryonic stem cells cultured in biodegradable scaffold repair infarcted myocardium in mice. , 2005, Sheng li xue bao : [Acta physiologica Sinica].

[4]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[5]  Milica Radisic,et al.  Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. , 2005, American journal of physiology. Heart and circulatory physiology.

[6]  Todd C McDevitt,et al.  Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. , 2003, Journal of biomedical materials research. Part A.

[7]  A. Hagège,et al.  Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. , 2003, Journal of the American College of Cardiology.

[8]  A. Zeiher,et al.  Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.

[9]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[10]  D. Kass,et al.  Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. , 2002, Journal of the American College of Cardiology.

[11]  S. Gogolewski,et al.  Long-term in vivo degradation and bone reaction to various polylactides. 1. One-year results. , 1997, Biomaterials.

[12]  A. Ganser,et al.  Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. , 2009, European heart journal.

[13]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Regulation and Contribution to Adult Neovascularization , 2002, Herz.

[14]  Lisa E. Freed,et al.  Accordion-Like Honeycombs for Tissue Engineering of Cardiac Anisotropy , 2008, Nature materials.

[15]  Rutger-Jan Swijnenburg,et al.  Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  M. Matsuzaki,et al.  Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. , 2006, American journal of physiology. Heart and circulatory physiology.

[17]  Payam Akhyari,et al.  Mechanical Stretch Regimen Enhances the Formation of Bioengineered Autologous Cardiac Muscle Grafts , 2002, Circulation.

[18]  I. Weissman,et al.  Stem Cells Units of Development, Units of Regeneration, and Units in Evolution , 2000, Cell.

[19]  J Kohyama,et al.  Brain from bone: efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. , 2001, Differentiation; research in biological diversity.

[20]  L. Griffith,et al.  Tissue Engineering--Current Challenges and Expanding Opportunities , 2002, Science.

[21]  D. Vaughan,et al.  Biologic properties of endothelial progenitor cells and their potential for cell therapy. , 2007, Progress in cardiovascular diseases.

[22]  M. Cho,et al.  Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. , 2007, Biomaterials.

[23]  P. Vliet,et al.  Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy , 2008, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[24]  Neil D. Theise,et al.  Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.

[25]  R J Cohen,et al.  Cardiac muscle tissue engineering : toward an in vitro model for electrophysiological studies , 1999 .

[26]  J. Naughton,et al.  Myoangiogenesis after cell patch cardiomyoplasty and omentopexy in a patient with ischemic cardiomyopathy. , 2005, Texas Heart Institute journal.

[27]  Y. Kuwabara,et al.  Use of omentum for mediastinal tracheostomy after total laryngoesophagectomy. , 2001, The Annals of thoracic surgery.

[28]  Randall J Lee,et al.  Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. , 2004, Journal of the American College of Cardiology.

[29]  Hidezo Mori,et al.  Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction , 2006, Nature Medicine.

[30]  Andreas Hess,et al.  Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts , 2006, Nature Medicine.

[31]  H. Sabbah,et al.  Passive epicardial containment prevents ventricular remodeling in heart failure. , 2000, The Annals of thoracic surgery.

[32]  Frank P. T. Baaijens,et al.  Effect of Strain Magnitude on the Tissue Properties of Engineered Cardiovascular Constructs , 2007, Annals of Biomedical Engineering.

[33]  E. Andreu,et al.  Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium , 2008, European journal of heart failure.

[34]  C. Bearzi,et al.  Activation of Cardiac Progenitor Cells Reverses the Failing Heart Senescent Phenotype and Prolongs Lifespan , 2008, Circulation research.

[35]  Richard T. Lee,et al.  Cardiac Progenitor Cells and Biotinylated Insulin-Like Growth Factor-1 Nanofibers Improve Endogenous and Exogenous Myocardial Regeneration After Infarction , 2009, Circulation.

[36]  Y. Yoon,et al.  Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia , 2003, Circulation.

[37]  Yan-qiu Yu,et al.  Ex Vitro Expansion of Human Placenta-Derived Mesenchymal Stem Cells in Stirred Bioreactor , 2009, Applied biochemistry and biotechnology.

[38]  Giulio Cossu,et al.  Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.

[39]  C. Henrikson,et al.  Antiarrhythmic Engineering of Skeletal Myoblasts for Cardiac Transplantation , 2005, Circulation research.

[40]  M. Soonpaa,et al.  Survey of studies examining mammalian cardiomyocyte DNA synthesis. , 1998, Circulation research.

[41]  E. Taraldsrud,et al.  Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[42]  W. Zimmermann,et al.  3D engineered heart tissue for replacement therapy , 2002, Basic Research in Cardiology.

[43]  P. Rentrop,et al.  Selective Intracoronary Thrombolysis in Acute Myocardial Infarction and Unstable Angina Pectoris , 1981, Circulation.

[44]  Hideki Uosaki,et al.  Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells , 2008, Circulation.

[45]  Doris A Taylor,et al.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.

[46]  Lars S. Maier,et al.  Generation of Functional Murine Cardiac Myocytes From Induced Pluripotent Stem Cells , 2008, Circulation.

[47]  J Folkman,et al.  Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.

[48]  M. Kawasuji,et al.  Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[49]  D L Eckberg,et al.  Mathematical treatment of autonomic oscillations. , 1999, Circulation.

[50]  D. Mann,et al.  Mechanisms and models in heart failure: A combinatorial approach. , 1999, Circulation.

[51]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[52]  K Rakusan,et al.  Morphometry of Human Coronary Capillaries During Normal Growth and the Effect of Age in Left Ventricular Pressure‐Overload Hypertrophy , 1992, Circulation.

[53]  J. Leor,et al.  Bioengineered Cardiac Grafts: A New Approach to Repair the Infarcted Myocardium? , 2000, Circulation.

[54]  É. Mousseaux,et al.  Skeletal Myoblast Transplantation in Ischemic Heart Failure: Long-Term Follow-Up of the First Phase I Cohort of Patients , 2006, Circulation.

[55]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[56]  A Haverich,et al.  In vitro engineering of heart muscle: artificial myocardial tissue. , 2002, The Journal of thoracic and cardiovascular surgery.

[57]  R. Stewart,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[58]  A. Zeiher,et al.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[59]  K. Kimura,et al.  Common marmoset embryonic stem cell can differentiate into cardiomyocytes. , 2008, Biochemical and biophysical research communications.

[60]  M. Kawasuji,et al.  Therapeutic angiogenesis with autologous hepatic tissue implantation and omental wrapping. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[61]  J. Isner,et al.  Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.

[62]  Patrick W Serruys,et al.  Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. , 2003, Journal of the American College of Cardiology.

[63]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[64]  Paul H Lerou,et al.  Generation of human-induced pluripotent stem cells , 2008, Nature Protocols.

[65]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[66]  Thomas Eschenhagen,et al.  Engineering Myocardial Tissue , 2005, Circulation research.

[67]  Cun-xian Song,et al.  Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization. , 2009, Texas Heart Institute Journal.

[68]  Richard T. Lee,et al.  Endothelial Cells Promote Cardiac Myocyte Survival and Spatial Reorganization: Implications for Cardiac Regeneration , 2004, Circulation.

[69]  M. Ashraf,et al.  Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine Signaling , 2006, Circulation research.

[70]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[71]  B. Fleischmann,et al.  Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation , 2004, Nature Medicine.

[72]  A. Terzic,et al.  Stem cell differentiation requires a paracrine pathway in the heart , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[73]  Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration , 2003 .

[74]  鈴木 亮.  Omentopexy enhances graft function in myocardial cell sheet transplantation , 2010 .

[75]  金森 太郎.  Hybrid surgical angiogenesis : omentopexy can enhance myocardial angiogenesis induced by cell therapy , 2006 .

[76]  Richard T. Lee,et al.  Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Randall J Lee,et al.  Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. , 2004, Tissue engineering.

[78]  Ursula Ravens,et al.  Cardiac tissue engineering. , 2002, Transplant immunology.

[79]  Rona Shofti,et al.  Electromechanical integration of cardiomyocytes derived from human embryonic stem cells , 2004, Nature Biotechnology.

[80]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[81]  川口 治子.  Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice , 2006 .

[82]  Theo Kofidis,et al.  Novel Injectable Bioartificial Tissue Facilitates Targeted, Less Invasive, Large-Scale Tissue Restoration on the Beating Heart After Myocardial Injury , 2005, Circulation.

[83]  Doris A Taylor,et al.  Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation , 1998, Nature Medicine.

[84]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[85]  Thomas Eschenhagen,et al.  Three‐dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[86]  E. Fiumana,et al.  Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function , 2008, Circulation research.

[87]  D. Fiszer,et al.  Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. , 2004, American heart journal.

[88]  G. Koh,et al.  Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. , 1996, The Journal of clinical investigation.

[89]  G. Ertl,et al.  Impact of different bone marrow cell preparations on left ventricular remodelling after experimental myocardial infarction , 2008, European journal of heart failure.

[90]  Mitsuo Umezu,et al.  Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces , 2002, Circulation research.